ELITE PHARMACEUTICALS INC /NV/ Quarterly Operating Lease, Weighted Average Discount Rate, Percent in pure from Q2 2019 to Q3 2024

Taxonomy & unit
us-gaap: pure
Description
Weighted average discount rate for operating lease calculated at point in time.
Summary
Elite Pharmaceuticals Inc /Nv/ quarterly Operating Lease, Weighted Average Discount Rate, Percent history and growth rate from Q2 2019 to Q3 2024.
  • Elite Pharmaceuticals Inc /Nv/ Operating Lease, Weighted Average Discount Rate, Percent for the quarter ending September 30, 2024 was 0.1 pure, a 66.7% increase year-over-year.
Operating Lease, Weighted Average Discount Rate, Percent, Quarterly (pure)
Operating Lease, Weighted Average Discount Rate, Percent, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 0.1 +0.04 +66.7% Sep 30, 2024 10-Q 2024-11-14
Q2 2024 0.1 +0.04 +66.7% Jun 30, 2024 10-Q 2024-08-14
Q1 2024 0.1 +0.04 +66.7% Mar 31, 2024 10-K 2024-07-01
Q4 2023 0.06 Dec 31, 2023 10-Q 2024-02-14
Q3 2023 0.06 Sep 30, 2023 10-Q 2024-11-14
Q2 2023 0.06 Jun 30, 2023 10-Q 2024-08-14
Q1 2023 0.06 0 0% Mar 31, 2023 10-K 2024-07-01
Q1 2022 0.06 0 0% Mar 31, 2022 10-K 2022-06-29
Q4 2021 0.06 0 0% Dec 31, 2021 10-Q 2022-02-14
Q3 2021 0.06 0 0% Sep 30, 2021 10-Q 2021-11-15
Q2 2021 0.06 0 0% Jun 30, 2021 10-Q 2021-08-16
Q1 2021 0.06 0 0% Mar 31, 2021 10-K 2021-06-14
Q4 2020 0.06 0 0% Dec 31, 2020 10-Q 2021-02-16
Q3 2020 0.06 0 0% Sep 30, 2020 10-Q 2020-11-16
Q2 2020 0.06 0 0% Jun 30, 2020 10-Q 2020-08-14
Q1 2020 0.06 Mar 31, 2020 10-K 2020-06-30
Q4 2019 0.06 Dec 31, 2019 10-Q 2020-02-10
Q3 2019 0.06 Sep 30, 2019 10-Q 2019-11-12
Q2 2019 0.06 Jun 30, 2019 10-Q 2019-08-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.